The global robotic endoscopy devices market size is expected to reach USD 4.5 billion by 2025, registering a CAGR 20.0% over a forecast period, according to a new report by Grand View Research, Inc. Rising preference for Minimally Invasive Surgical (MIS) procedures, recent product approvals by the regulatory bodies such as the U.S. Food and Drug Administration (FDA), and prevalence of chronic diseases are the key factors driving the growth.
Robotic
endoscopy devices are developed to overcome the limitations of standard
diagnostic and therapeutic procedures. The benefits of robotic endoscopy
devices in surgical procedures include fast recovery time, reduced post-surgery
complications, and minimized scars, thus reduced the duration of hospital
stays. Such benefits are anticipated to drive the robotic endoscopy devices
market in the forthcoming years.
Factors
such as new product developments, approvals, and technological advancements are
projected to further fuel the market growth. For instance, in March 2018, Auris
Health (Johnson & Johnson) announced the FDA clearance for its Monarch
Endoscopy platform. The robotic endoscopy system developed by Medineering GmbH
received CE mark approval in the European Union in 2016. Medineering also
received the CE approval for its endoscope robot in February 2018.
Full Research Report On Robotic Endoscopy Devices Market Visit Here:
https://www.grandviewresearch.com/industry-analysis/robotic-endoscopy-devices-market
Further key
findings from the report suggest:
- In 2018,
therapeutic segment held the largest revenue share owing to the rising
adoption of robotic endoscopy devices for surgical intervention coupled
with increasing number of market players developing new products for
various surgical procedures
- Hospitals
held the largest revenue share in 2018 owing to the availability of large
funds with the hospitals in the developed regions coupled with rising
adoption of the devices for performing various types of surgical
procedures
- North America
held the largest revenue share in 2018, owing to the financial capability
of the hospitals to make investments in these devices and general
awareness about robot assisted medical procedures
- Asia Pacific
expected to expand at the fastest CAGR over the forecast period owing to
the factors, such as rising disposable income, healthcare expenditure, and
prevalence of chronic diseases
- Key players
operating in the robotic endoscopy devices market include Intuitive
Surgical, Inc.; TransEnterix, Inc.; Auris Health (Johnson & Johnson);
Medineering GmbH; and Medrobotics Corporation
Request a Sample Copy of the Report @
https://www.grandviewresearch.com/industry-analysis/robotic-endoscopy-devices-market/request/rs1
Grand View Research has
segmented the global robotic endoscopy devices market on the basis of product,
application, end use, and region:
Robotic Endoscopy
Devices Product Outlook (Revenue, USD Million, 2014 - 2025)
- Diagnostic
- Therapeutic
Robotic Endoscopy
Devices Application Outlook (Revenue, USD Million, 2014 - 2025)
- Laparoscopy
- Bronchoscopy
- Colonoscopy
Robotic Endoscopy
Devices End Use Outlook (Revenue, USD Million, 2014 - 2025)
- Hospitals
- Ambulatory Surgical Centers
- Others
Robotic Endoscopy
Devices Regional Outlook (Revenue, USD Million, 2014 - 2025)
- North America
- U.S.
- Canada
- Europe
- U.K.
- Germany
- Spain
- France
- Italy
- Asia Pacific
- China
- Japan
- India
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment